DigestRedComo funciona
Red
/
Empresas
Qu
No verificado

QurAlis Corporation

Sobre qué escribimos

BiotecnologíaCienciaEventosFarmacéuticaSalud

7 Comunicados de prensa

Ver todos los comunicados de prensa
02/12/2025
Biotecnología
Farmacéutica
Salud
QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener, at American Epilepsy Society 2025 Annual Meeting
Fuente
QurAlis Corporation
Editor
Business Wire
1.00
0
20/11/2025
Biotecnología
Sanidad
Salud
Farmacéutica
Web y redes sociales
Ferias y Congresos
Eventos
QurAlis to Participate in Piper Sandler 37th Annual Healthcare Conference
Fuente
QurAlis Corporation
Editor
Business Wire
1.00
0
10/11/2025
QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer
Fuente
QurAlis Corporation
Editor
Business Wire
1.00
0
03/11/2025
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Eventos
Ferias y Congresos
QurAlis to Participate in Upcoming Investor Conferences in November
Fuente
QurAlis Corporation
Editor
Business Wire
1.00
0
20/08/2025
Biotecnología
Farmacéutica
Salud
Eventos
QurAlis to Participate in Upcoming Investor Conferences in September
Fuente
QurAlis Corporation
Editor
Business Wire
1.00
0
18/06/2025
Salud
Mercado inmobiliario
Tecnología de la construcción
Ciencia
Farmacéutica
Biotecnología
QurAlis Announces New Global Headquarters
Fuente
QurAlis Corporation
Editor
Business Wire
1.00
0
15/05/2025
Mercado laboral
Industria
Ciencia
Biotecnología
Salud
Universidad
Farmacéutica
Escuela/Educación
QurAlis Announces Exclusive License on Novel Mechanism for Fragile X Syndrome (FXS) to Enable Development of First Potential Disease-Modifying Therapy
Fuente
QurAlis Corporation
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0